Hirman J - Search Results

1

Long-term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication-overuse headache.

Blumenfeld A, Kudrow D, McAllister P, Boserup LP, Hirman J, Cady R. Blumenfeld A, et al. Among authors: hirman j. Headache. 2024 Jul-Aug;64(7):738-749. doi: 10.1111/head.14767. Epub 2024 Jun 24. Headache. 2024. PMID: 38924044 Clinical Trial.

2

Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials.

Quattrone A, Franzmeier N, Huppertz HJ, Klietz M, Roemer SN, Boxer AL, Levin J, Höglinger GU; AL‐108‐231 Investigators, the Tauros MRI Investigators, the PASSPORT Study Group, the DESCRIBE‐PSP Group. Quattrone A, et al. Mov Disord. 2024 Aug;39(8):1329-1342. doi: 10.1002/mds.29866. Epub 2024 Jun 2. Mov Disord. 2024. PMID: 38825840

3

Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex.

Porreca F, Navratilova E, Hirman J, van den Brink AM, Lipton RB, Dodick DW. Porreca F, et al. Among authors: hirman j. Cephalalgia. 2024 Mar;44(3):3331024241238153. doi: 10.1177/03331024241238153. Cephalalgia. 2024. PMID: 38477313 Free article. Review.

4

Improving to Four or Fewer Monthly Headache Days Per Month Provides a Clinically Meaningful Therapeutic Target for Patients with Chronic Migraine.

Kaniecki RG, Friedman DI, Asher D, Hirman J, Cady R. Kaniecki RG, et al. Among authors: hirman j. Pain Ther. 2023 Oct;12(5):1179-1194. doi: 10.1007/s40122-023-00525-x. Epub 2023 Jun 28. Pain Ther. 2023. PMID: 37378754 Free PMC article.

5

Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial.

Starling AJ, Cowan RP, Buse DC, Diener HC, Marmura MJ, Hirman J, Brevig T, Cady R. Starling AJ, et al. Among authors: hirman j. Headache. 2023 Feb;63(2):264-274. doi: 10.1111/head.14434. Epub 2023 Jan 12. Headache. 2023. PMID: 36633219 Clinical Trial.

6

Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure.

Tepper SJ, Ailani J, Ray S, Hirman J, Shrewsbury SB, Aurora SK. Tepper SJ, et al. Among authors: hirman j. J Headache Pain. 2022 Nov 22;23(1):148. doi: 10.1186/s10194-022-01519-4. J Headache Pain. 2022. PMID: 36414952 Free PMC article. Review.

7

Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies.

Pozo-Rosich P, Dodick DW, Ettrup A, Hirman J, Cady R. Pozo-Rosich P, et al. Among authors: hirman j. BMC Neurol. 2022 Oct 25;22(1):394. doi: 10.1186/s12883-022-02914-9. BMC Neurol. 2022. PMID: 36284281 Free PMC article. Clinical Trial.

8

A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery.

Rosenbaum E, Chugh R, Ryan CW, Agulnik M, Milhem MM, George S, Jones RL, Chmielowski B, Van Tine BA, Tawbi H, Elias AD, Read WL, Budd GT, Qin LX, Rodler ET, Hirman J, Weiden P, Bennett CM, Livingston PO, Ragupathi G, Hansen D, D'Angelo SP, Tap WD, Schwartz GK, Maki RG, Carvajal RD. Rosenbaum E, et al. Among authors: hirman j. Eur J Cancer. 2022 Nov;176:155-163. doi: 10.1016/j.ejca.2022.09.003. Epub 2022 Oct 8. Eur J Cancer. 2022. PMID: 36215947 Free PMC article. Clinical Trial.

9

Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.

Cowan RP, Marmura MJ, Diener HC, Starling AJ, Schim J, Hirman J, Brevig T, Cady R. Cowan RP, et al. Among authors: hirman j. J Headache Pain. 2022 Sep 6;23(1):115. doi: 10.1186/s10194-022-01482-0. J Headache Pain. 2022. PMID: 36068494 Free PMC article. Clinical Trial.

10

Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab.

Blumenfeld A, Ettrup A, Hirman J, Ebert B, Cady R. Blumenfeld A, et al. Among authors: hirman j. BMC Neurol. 2022 Jul 8;22(1):251. doi: 10.1186/s12883-022-02774-3. BMC Neurol. 2022. PMID: 35804294 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters